2,4,6-trihydroxybenzaldehyde has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choy, YY; Forester, SC; Oteiza, PI; Waterhouse, AL | 1 |
1 other study(ies) available for 2,4,6-trihydroxybenzaldehyde and Colonic Neoplasms
Article | Year |
---|---|
The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals.
Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; Humans; NF-kappa B; Organic Cation Transporter 1; Signal Transduction; STAT1 Transcription Factor; Transcription Factor AP-1 | 2014 |